Existing drug is shown to inhibit SARS-CoV-2 virus
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.
Jul 21, 2021
0
236
Attention deficit hyperactivity disorder (ADHD) affects about 7% of children, with a two out of three chance of persisting into adulthood. This neurodevelopmental disorder is characterized by concentration difficulties, increased ...
Jun 29, 2021
0
5
The latest setback for Johnson & Johnson's COVID-19 vaccine was the U.S. Food and Drug Administration's order on June 11, 2021, to discard 60 million doses that failed to meet quality and safety guidelines. A Baltimore manufacturing ...
Jun 24, 2021
0
1
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
Authorities in 92 countries shut down 113,000 websites and online marketplaces selling counterfeit or illicit medicines and medical products last month, including vast quantities of fake COVID-19 tests and face masks, Interpol ...
Jun 8, 2021
0
0
A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support empowering the federal government to negotiate lower prices of brand-name prescription drugs covered by Medicare. ...
Jun 3, 2021
0
1
In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
May 26, 2021
0
326
Two articles published online today by Alzheimer's & Dementia: Translational Research & Clinical Interventions, a journal of the Alzheimer's Association, show substantial changes in the focus and funding of clinical trials ...
May 25, 2021
0
1
An expert panel convened by the Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer's ...
May 18, 2021
1
6
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being ...
May 6, 2021
0
12